Reuters [21 April, 2017]
“Progress in fighting tropical diseases but funding and conflicts pose challenges”
Radio Okapi [20 April, 2017]
“RDC: des efforts sont nécessaires pour éliminer les maladies tropicales négligées” – “DRC: efforts needed to eliminate neglected tropical diseases”
Devex [20 April, 2017]
“Commitments made on neglected tropical diseases at WHO summit”
PLOS NTDs [20 April, 2017]
“Neglected tropical diseases: A DFID perspective”
Le Temps [19 April, 2017]
“Des progrès dans la lutte contre les maladies tropicales négligées” – “Progress in addressing neglected tropical diseases”
Le Monde [19 April, 2017]
“Mobilisation contre les maladies tropicales négligées” – “Mobilization against neglected tropical diseases”
PLOS Blog [19 April, 2017]
“Combatting neglected tropical diseases: much progress, but millions of neglected patients lack access to care”
Devex [18 April, 2017]
“Strides in progress on neglected tropical diseases as global partners meet”
SEMTSI 2017
X National Congress of Tropical Medicine and International Health
October 23-25, 2017
Bilbao, Spain
Representatives from DNDi and GARDP took part in the event.
ECTMIH 2017
October 16-20, 2017
Antwerp, Belgium
DNDi presented on sleeping sickness, visceral leishmaniasis, mycetoma, and onchocerciasis.
Financial Times [18 April, 2017]
“The long road to elimination of neglected tropical diseases”
Financial Times [18 April, 2017]
“More engagement on neglected tropical diseases needed from drugmakers”
Healio [12 April, 2017]
“GHIT Fund awards $23 million for malaria, NTDs research”
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
International Workshop on Onchocerciasis-associated Epilepsy (OAE)
October 12-14, 2017
Antwerp, Belgium
Belén Pedrique, Medical Manager, DNDi, participated in the first international workshop on onchocerciasis-associated epilepsy (OAE).
IMTechCon 2017
October 4-6, 2017
Chandigarh, India
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.
ReAct
Action on Antibiotic Resistance (ReAct) Africa Annual Conference 2017
September 18-19, 2017
Machakos, Kenya
DNDi Africa’s Director, Monique Wasunna, gave a presentation on DNDi‘s various programme models.
XXV Brazilian Parasitology Congress
September 3-6, 2017
Búzios, Rio de Janeiro, Brazil
DNDi presented an abstract on LOLA hit-to-lead results.
Gordon Research Conference
66th Gordon Research Conference on Natural Products and Bioactive Compounds
July 30, 2017
New Hampshire, USA
Benjamin Perry, Open Innovations Senior Manager, Discovery, DNDi presented at the event.